Figures & data
Figure 1 Flow chart of participants.
![Figure 1 Flow chart of participants.](/cms/asset/2eeab6a5-7c82-4570-9026-9ad977eaee51/dcia_a_306255_f0001_c.jpg)
Table 1 Baseline Demographic and Clinical Characteristics Between Groups
Table 2 Between-Group Difference on Primary Outcomes After 7 Days Treatment (PP Analysis, n=200)
Figure 2 Treatment difference and non-inferiority margin. (A) Non-inferiority test for the modified intention-to-treat dataset, n = 209. (B) Non-inferiority test for the per-protocol dataset, n = 200.
![Figure 2 Treatment difference and non-inferiority margin. (A) Non-inferiority test for the modified intention-to-treat dataset, n = 209. (B) Non-inferiority test for the per-protocol dataset, n = 200.](/cms/asset/2dffb010-ce33-49bc-a5c9-5c1c3900e649/dcia_a_306255_f0002_c.jpg)
Table 3 Median (IQR) Secondary Outcomes Scores for Each Group, and Results of GEE Analysis (PP Analysis, n = 200; Experimental Group n = 105, Control Group n = 95)